LoginRegister
    Aurobindo Pharma recalls 2352 bottles of Simvastatin tablets over labelling issueAurobindo Pharma recalls 2352 bottles of Simvastatin tablets over labelling issue
    AstraZeneca Imfinzi shows to increase survival in aggressive lung cancerAstraZeneca Imfinzi shows to increase survival in aggressive lung cancer
    Amgen drug AMG510 shrinks lung cancer tumours in half of patients in early-stage trialAmgen drug AMG510 shrinks lung cancer tumours in half of patients in early-stage trial
    Purdue Pharma expected to file for bankruptcy post opioid talks failPurdue Pharma expected to file for bankruptcy post opioid talks fail
    Pharma, Bio-Pharma manufacturing units to follow Apprentices Act: CDSCO issues advisoryPharma, Bio-Pharma manufacturing units to follow Apprentices Act: CDSCO issues advisory
    Novo Nordisk in race with rivals Sanofi, Eli Lilly; to offer generic diabetes drug at 50pc discountNovo Nordisk in race with rivals Sanofi, Eli Lilly; to offer generic diabetes drug at 50pc discount
    Boehringer Ingelheim gets USFDA nod for Ofev capsules to treat lung disorderBoehringer Ingelheim gets USFDA nod for Ofev capsules to treat lung disorder
    Novartis wins USFDA breakthrough tag for Capmatinib to treat lung cancerNovartis wins USFDA breakthrough tag for Capmatinib to treat lung cancer
    Bristol-Myers blockbuster Opdivo fails to meet goal of brain tumour studyBristol-Myers blockbuster Opdivo fails to meet goal of brain tumour study
    Cigna new plan to cover expensive gene therapies including Novartis Zolgensma, LuxturnaCigna new plan to cover expensive gene therapies including Novartis Zolgensma, Luxturna
    Fight for Vildagliptin: Natco goes to court against NovartisFight for Vildagliptin: Natco goes to court against Novartis
    Lupin gets USFDA nod for generic version of Emend Injection to prevent vomiting associated with chemotherapyLupin gets USFDA nod for generic version of Emend Injection to prevent vomiting associated with...
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X